Click below to download external research studies found relevant by American Integrative Pharmacy.
Lyme Disease
- Dapsone for Lyme and Babesia
- ALS and Lyme Disease Press Conference
- Innovative Rx of Neurodegenerative
Thyroid and Other Hormones
- Testosterone -Absorption and Efficacy of Multiple Hormones Delivered in a Single Cream Applied to the Mucous Membranes of the Labia and Vagina
- Transdermal testosterone therapy improves well-being mood and sexual function in premenopausal women
- Holtorf, K. Peripheral Thyroid Hormone Conversion and Its Impact on TSH and Metabolic Activity
- Holtorf, K. Thyroid Hormone Transport into Cellular Tissue
- Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors
ALS
- ALS – EXPRESS NEWSPAPERS
- Show of strength Doctors told Steve Smith he was dying of ALS. He is now convinced that is not true.
- ALS and Lyme Disease Press Conference
- Minocycline Creatine ALS
- The Use of Dapsone as a Novel “Persister” Drug in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome
- Lithium and ALS
- Stronger Every Day With an iron will and an unconventional new treatment, Charlies Smith is going toe-to-toe with ALS
- Chronic Bacterial and Viral Infections in Neurodegenerative and Neurobehavioral Diseases
Low Dose Naltrexone
- Low Dose Naltrexone for Children with Crohn’s Disease
- Safety of Low Dose Naltrexone for Children with Crohn’s Disease
- Low-Dose Naltrexone for Pruritus in Systemic Sclerosis
- Low Dose Naltrexone for Crohn’s Disease
- Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis
- The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
- Treatment of Complex Regional Pain Syndrome (CRPS) Using Low Dose Naltrexone (LDN)
- Low-Dose Naltrexone for the Treatment of Fibromyalgia
- Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia
- Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study
- Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants
- Off-Label, Low-Dose Naltrexone for Refractory Painful Diabetic Neuropathy
- A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study.
